熱門資訊> 正文

永旺Bizerma宣布任命首席执行官

2025-04-22 04:34

AEON Biopharma (NYSE:AEON) announced the appointment of Rob Bancroft as president and chief executive officer, effective April 29, 2025.
Bancroft will also join AEON’s board of directors.
Prior to joining AEON, Bancroft served as general manager of the Therapeutics business at Revance Therapeutics.
Source: Press release

More on AEON Biopharma

AEON Biopharma shares plunge as it announces reverse stock split
AEON Biopharma receives NYSE non-compliance notice
Financial information for AEON Biopharma

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。